Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Zoller

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
Infection|April 23, 2021
Clinical and virological characteristics of hospitalised COVID-19 patients in a German tertiary care centre during the first wave of the SARS-CoV-2 pandemic: a prospective observational studyCharlotte Thibeault, Barbara Mühlemann, Elisa T Helbig, et al.
The Lancet. Infectious Diseases|July 1, 2026
Community-based tuberculosis screening with computer-aided detection technology alone and in combination with point-of-care C-reactive protein testing: a paired screen-positive trialKlaus Reither, Fiona Vanobberghen, Anna Verjans, et al.
Blood Cancer Journal|July 19, 2022
BRD9 degraders as chemosensitizers in acute leukemia and multiple myelomaEllen Weisberg, Basudev Chowdhury, Chengcheng Meng, et al.
Malaria Journal|February 2, 2017
Severe malaria in Europe: an 8-year multi-centre observational studyFlorian Kurth, Michel Develoux, Matthieu Mechain, et al.
Cancer Cell|July 19, 2024
Mammalian SWI/SNF complex activity regulates POU2F3 and constitutes a targetable dependency in small cell lung cancerLeslie Duplaquet, Kevin So, Alexander W Ying, et al.
Brain, Behavior, & Immunity - Health|June 8, 2026
An externally validated machine learning algorithm for predicting mental and physical health outcomes three months post-hospitalization for severe viral infection with SARS-CoV-2Katharina Schultebraucks, Sapir Gershov, Felix Fischer, et al.
Cancer Research|June 26, 2026
BRD9 Degraders Unleash GBAF Chromatin Remodeling Activity in Synovial SarcomaJinxiu Li, Mary L Nelson, Li Li, et al.
Nature Communications|August 19, 2024
Author Correction: DCAF1-based PROTACs with activity against clinically validated targets overcoming intrinsic- and acquired-degrader resistanceMartin Schröder, Martin Renatus, Xiaoyou Liang, et al.
The American Journal of Tropical Medicine and Hygiene|July 20, 2017
Schistosomiasis in European Travelers and Migrants: Analysis of 14 Years TropNet Surveillance DataTilman Lingscheid, Florian Kurth, Jan Clerinx, et al.
Nature Communications|January 4, 2024
DCAF1-based PROTACs with activity against clinically validated targets overcoming intrinsic- and acquired-degrader resistanceMartin Schröder, Martin Renatus, Xiaoyou Liang, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
Infection|April 23, 2021
Clinical and virological characteristics of hospitalised COVID-19 patients in a German tertiary care centre during the first wave of the SARS-CoV-2 pandemic: a prospective observational studyCharlotte Thibeault, Barbara Mühlemann, Elisa T Helbig, et al.
The Lancet. Infectious Diseases|July 1, 2026
Community-based tuberculosis screening with computer-aided detection technology alone and in combination with point-of-care C-reactive protein testing: a paired screen-positive trialKlaus Reither, Fiona Vanobberghen, Anna Verjans, et al.
Blood Cancer Journal|July 19, 2022
BRD9 degraders as chemosensitizers in acute leukemia and multiple myelomaEllen Weisberg, Basudev Chowdhury, Chengcheng Meng, et al.
Malaria Journal|February 2, 2017
Severe malaria in Europe: an 8-year multi-centre observational studyFlorian Kurth, Michel Develoux, Matthieu Mechain, et al.
Cancer Cell|July 19, 2024
Mammalian SWI/SNF complex activity regulates POU2F3 and constitutes a targetable dependency in small cell lung cancerLeslie Duplaquet, Kevin So, Alexander W Ying, et al.
Brain, Behavior, & Immunity - Health|June 8, 2026
An externally validated machine learning algorithm for predicting mental and physical health outcomes three months post-hospitalization for severe viral infection with SARS-CoV-2Katharina Schultebraucks, Sapir Gershov, Felix Fischer, et al.
Cancer Research|June 26, 2026
BRD9 Degraders Unleash GBAF Chromatin Remodeling Activity in Synovial SarcomaJinxiu Li, Mary L Nelson, Li Li, et al.
Nature Communications|August 19, 2024
Author Correction: DCAF1-based PROTACs with activity against clinically validated targets overcoming intrinsic- and acquired-degrader resistanceMartin Schröder, Martin Renatus, Xiaoyou Liang, et al.
The American Journal of Tropical Medicine and Hygiene|July 20, 2017
Schistosomiasis in European Travelers and Migrants: Analysis of 14 Years TropNet Surveillance DataTilman Lingscheid, Florian Kurth, Jan Clerinx, et al.
Nature Communications|January 4, 2024
DCAF1-based PROTACs with activity against clinically validated targets overcoming intrinsic- and acquired-degrader resistanceMartin Schröder, Martin Renatus, Xiaoyou Liang, et al.
Pageof 9